The weight-loss drug boom is beginning to show signs of a slowdown as employers and insurers pull back on coverage, signalling the market could be entering a more restrained phase after years of breakneck expansion
therefore, an important step to overcome this resistance is to understand the underlying molecular and metabolic mechanisms
Citation: Farjas P, Regard A, Petitcolas C, The Development Path to Bioequivalence for a Nasal Spray
In skincare, this antioxidant is valued for its ability to support a more balanced and even-looking skin tone by helping regulate oxidative stress, which is one of the factors linked to dullness and uneven appearance
In gastrointestinal models, TB-500 enhances epithelial migration, accelerates wound closure, and modulates inflammatory responses
Europe: The Second-Largest Market Europe held the second-largest share of 23% in 2025 and is expected to grow at a notable CAGR of 13.1% during the projection period, driven mainly by expanding reimbursement and treatment access